Magnetically-Guided Nanoparticle Drug Delivery
This presentation is the property of its rightful owner.
Sponsored Links
1 / 1

Magnetite Nanoparticles PowerPoint PPT Presentation


  • 83 Views
  • Uploaded on
  • Presentation posted in: General

Magnetically-Guided Nanoparticle Drug Delivery Seth Baker, RET Fellow 2011 Percy Julian Middle School RET Mentor: Prof. Andreas A. Linninger Chicago Science Teacher Research (CSTR) Program – NSF-RET 2011. Introduction. Magnetite Nanoparticles. Superparamagnetic Properties. Motivation

Download Presentation

Magnetite Nanoparticles

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Magnetite nanoparticles

Magnetically-Guided Nanoparticle Drug DeliverySeth Baker, RET Fellow 2011Percy Julian Middle SchoolRET Mentor: Prof. Andreas A. LinningerChicago Science Teacher Research (CSTR) Program – NSF-RET 2011

Introduction

Magnetite Nanoparticles

Superparamagnetic Properties

  • Motivation

  • Direct application for improved medical treatments of neurological disorders

    • - Alzheimer’s, Parkinson’s, autism, cerebrovascular disease, abnormal vascular structures (tumors), and stroke conditions.

  • Improved pharmacokinetics and pharmacodynamics

    • - Limiting therapeutics to targeted sites reduces systemic distribution/toxicity

    • - Targeted delivery can lower dosage and reduce cytotoxicity

  • Objective

  • Many therapeutic drugs for treatment of neurological conditions can cause systemic toxicity due to limited targeting of effected tissue. Magnetically-guided drug delivery offers treatment options that can reach site specific areas of the brain. Testing is needed to determine a standard protocol for infusing and guiding nanoparticles. Use of agarose brain phantoms can eliminate preliminary animal testing.

Biocompatible

cerebral artery

Iron ions metabolize and are biodegradable in vivo

Superparamagnetic relaxation

Spin glass arrangement

Dipole alignment in the presence of a magnet

Nanoscale

Functionalization

Nanoparticles can be coated with various agents

Experimental Design

Convection Enhanced Delivery

Capillary Experiments

Step Catheters

Capillary experiment set up with 1.0 ml syringe and 30 nm magnetite

173 pound pull force magnet under capillary infused agarose gel

35 and 173 pound pull force magnets affect on capillary experiment

0.26 mm diameter step catheter tip

Rat Brain Tests

  • New Era Pump System syringe pump

  • Polyethylene tubing (various gauges)

  • Polymer step catheters (various gauges)

  • 1.0 ml medical syringes

  • Magnetic nanoparticles (various diameters)

  • Sodium Hydroxide

  • Magnets of various pull force

  • 0.6% Agarose gel

  • Prussian Blue Stain

  • Plastic cell blocks

  • Surfactants

  • Glass slides for slicing gel

  • Canon EOS Rebel Xti

  • Rat brain tissue

Coronal slices of rat brain showing distribution profile of Prussia blue dye.

30 nm magnetite particles delivered on rat brain tissue to determine susceptibility to nanoparticles.

Coronal slices of rat brain after placed in Prussian blue dye to determine untreated brain susceptibility to staining.

Testing Magnetic Susceptibility

Results

Magnetic force was below the injection site and syringe needles were place ¼ inch above magnet in each trial. Red line indicates syringe placement.

There is a general attraction of magnetic nanoparticles through the agarose toward the magnets.

Control for capillary infusion

35 lb pull force magnet trial

30 nanometer Magnetite particles above a 173 pound pull force magnet at 4 minutes

30 nanometer Magnetite particles above a 173 pound pull force magnet at 8 minutes

30 nanometer Magnetite particles above a 173 pound pull force magnet at 0 minutes

173 lb pull force magnet trial

Acknowledgements

Future Studies

Conclusion

Improved infusion of magnetic nanoparticles

Studying various techniques to reduce the agglomeration of magnetic nanoparticles through the use of various surfactants as well as various catheter design, tube diameters, and nanoparticle concentrations.

Rat brain infusion

Improve methods of introducing magnetic nano-particles into fresh brain tissue.

  • Magnetic nanoparticles indicate some attraction toward a magnet during capillary experiments in agarose gel brain phantoms.

  • Step design for polymer catheters can reduce reflux during convection enhanced delivery of nanoparticles.

  • Larger diameter nanoparticles tend to agglomerate more rapidly than smaller diameter particles.

  • NSF CBET EEC-0743068 Grant, Chicago Science Teacher Research (CSTR) Program Director, A. Linninger

  • Members of LPPD, Andreas Linninger, Eric Lueshen, Sukhi Basati, Indu Venugopal, Joe Kanikunnel ,Bhargav Desai

  • RET Fellows at UIC


  • Login